PDGF-mediated PI3K/AKT/β-catenin signaling regulates gap junctions in corpus cavernosum smooth muscle cells

Exp Cell Res. 2018 Jan 15;362(2):252-259. doi: 10.1016/j.yexcr.2017.11.025. Epub 2017 Nov 22.

Abstract

Erectile dysfunction (ED) is the most common sexual disorder that men report to healthcare providers. Gap junctions (GJs) are thought to be responsible for synchronous shrinkage of corpus cavernosum smooth muscle cells (CCSMCs), and play thus an important role in the maintenance of an erection. Hypoxia has been suggested as a pathological mechanism underlying ED. Here we demonstrate that hypoxia increased the expression of platelet-derived growth factor (PDGF) and the main GJ component connexin (Cx)43 in CCSMCs. Inhibiting PDGF receptor (PDGFR) activity decreased Cx43 expression. Treatment with different concentrations of PDGF increased the levels of phosphorylated protein kinase B (AKT), β-catenin, and Cx43, whereas inhibition of PDGFR or activation of phosphatidylinositol 3 kinase (PI3K)/AKT signaling altered β-catenin and Cx43 expression. Meanwhile, silencing β-catenin resulted in the downregulation of Cx43. These results demonstrate that PDGF secretion by CCSMCs and vascular endothelial cells is enhanced under hypoxic conditions, leading to increased Cx43 expression through PI3K/AKT/β-catenin signaling and ultimately affecting GJ function in ED. Thus, targeting this pathway is a potential therapeutic strategy for the treatment of ED.

Keywords: AKT; Connexin 43; Erectile dysfunction; PI3K; Platelet-derived growth factor; β-catenin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Hypoxia / genetics
  • Connexin 43 / genetics*
  • Erectile Dysfunction / genetics*
  • Erectile Dysfunction / pathology
  • Gap Junctions / genetics
  • Gap Junctions / pathology
  • Gene Expression Regulation / drug effects
  • Humans
  • Male
  • Myocytes, Smooth Muscle / metabolism
  • Myocytes, Smooth Muscle / pathology
  • Penis / metabolism
  • Penis / physiopathology
  • Phosphatidylinositol 3-Kinases / genetics
  • Platelet-Derived Growth Factor / administration & dosage
  • Proto-Oncogene Proteins c-akt / genetics
  • Rats
  • Receptors, Platelet-Derived Growth Factor / genetics*
  • Signal Transduction / drug effects
  • beta Catenin / genetics*

Substances

  • Connexin 43
  • Ctnnb1 protein, rat
  • Platelet-Derived Growth Factor
  • beta Catenin
  • platelet-derived growth factor A
  • Phosphatidylinositol 3-Kinases
  • Receptors, Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-akt